New flow cytometric assays for monitoring cell-mediated cytotoxicity

References

• Kagi D, Ledermann B, Burki K, Zinkernagel RM, Hengartner H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo.Annu. Rev. Immunol.14, 207–232 (1996).
   PubMed Web of Science ®Google Scholar
• Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat. Rev. Immunol.3, 361–370 (2003).
   PubMed Web of Science ®Google Scholar
• Nagata S, Golstein P. The Fas death factor. Science267, 1449–1456 (1995).
   PubMed Web of Science ®Google Scholar
• Peter ME, Krammer PH. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ.10, 26–35 (2003).
   PubMed Web of Science ®Google Scholar
• Poehlein CH, Hu HM, Yamada J et al. TNF plays an essential role in tumor regression after adoptive transfer of perforin/IFN-γ double knockout effector T cells. J. Immunol.170, 2004–2013 (2003).
   PubMed Web of Science ®Google Scholar
• Dobrzanski MJ, Reome JB, Hollenbaugh JA, Hylind JC, Dutton RW. Effector cell-derived lymphotoxin a and Fas ligand, but not perforin, promote Tc1 and Tc2 effector cell-mediated tumor therapy in established pulmonary metastases. Cancer Res.64, 406–414 (2004).
   PubMedGoogle Scholar
• Pulaski BA, Smyth MJ, Ostrand-Rosenberg S. Interferon-γ-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma. Cancer Res.62, 4406–4412 (2002).
   PubMed Web of Science ®Google Scholar
• Gurlo T, von Grafenstein H. Antigen-independent cross-talk between macrophages and CD8+ T cells facilitates their cooperation during target destruction. Int. Immunol.15, 1063–1071 (2003).
   PubMedGoogle Scholar
• Nomi H, Tashiro-Yamaji J, Yamamoto Y et al. Acute rejection of allografted CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient mice. J. Immunol.179, 2180–2186 (2007).
   PubMedGoogle Scholar
• Blankenstein T. The role of tumor stroma in the interaction between tumor and immune system. Curr. Opin. Immunol.17, 180–186 (2005).
   PubMed Web of Science ®Google Scholar
• Brunner KT, Mauel J, Cerottini JC, Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology14, 181–196 (1968).
   PubMed Web of Science ®Google Scholar
• Lyerly HK. Quantitating cellular immune responses to cancer vaccines. Semin. Oncol.30, 9–16 (2003).
   PubMed Web of Science ®Google Scholar
• Kalyuzhny AE. Chemistry and biology of the ELISpot assay. Methods Mol. Biol.302, 15–31 (2005).
   PubMedGoogle Scholar
• Scheibenbogen C, Romero P, Rivoltini L et al. Quantitation of antigen-reactive T cells in peripheral blood by IFNγ-ELISpot assay and chromium-release assay: a four-centre comparative trial. J. Immunol. Methods244, 81–89 (2000).
   PubMed Web of Science ®Google Scholar
• Schmittel A, Keilholz U, Thiel E, Scheibenbogen C. Quantification of tumor-specific T lymphocytes with the ELISpot assay. J. Immunother.23, 289–295 (2000).
   PubMed Web of Science ®Google Scholar
• Derby EG, Reddy V, Nelson EL et al. Correlation of human CD56+ cell cytotoxicity and IFN-γ production. Cytokine13, 85–90 (2001).
   PubMedGoogle Scholar
• Rininsland FH, Helms T, Asaad RJ, Boehm BO, Tary-Lehmann M. Granzyme B ELISpot assay for ex vivo measurements of T cell immunity. J. Immunol. Methods240, 143–155 (2000).
   PubMedGoogle Scholar
• Shafer-Weaver K, Rosenberg S, Strobl S et al. Application of the granzyme B ELISpot assay for monitoring cancer vaccine trials. J. Immunother.29, 328–335 (2006).
   PubMedGoogle Scholar
• Maecker HT. Multiparameter flow cytometry monitoring of T cell responses. Methods Mol. Biol.485, 375–391 (2009).
   PubMedGoogle Scholar
• Maino VC, Picker LJ. Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression. Cytometry34, 207–215 (1998).
   PubMedGoogle Scholar
• Bolton DL, Roederer M. Flow cytometry and the future of vaccine development. Expert Rev. Vaccines8, 779–789 (2009).
   PubMed Web of Science ®Google Scholar
• He L, Hakimi J, Salha D et al. A sensitive flow cytometry-based cytotoxic T-lymphocyte assay through detection of cleaved caspase 3 in target cells. J. Immunol. Methods304, 43–59 (2005).
   PubMedGoogle Scholar
• Jerome KR, Sloan DD, Aubert M. Measurement of CTL-induced cytotoxicity: the caspase 3 assay. Apoptosis8, 563–571 (2003).
   PubMed Web of Science ®Google Scholar
• Liu L, Chahroudi A, Silvestri G et al. Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates. Nat. Med.8, 185–189 (2002).
   PubMed Web of Science ®Google Scholar
• Liu L, Packard BZ, Brown MJ, Komoriya A, Feinberg MB. Assessment of lymphocyte-mediated cytotoxicity using flow cytometry. Methods Mol. Biol.263, 125–140 (2004).
   PubMedGoogle Scholar
• Chahroudi A, Silvestri G, Feinberg MB. Measuring T cell-mediated cytotoxicity using fluorogenic caspase substrates. Methods31, 120–126 (2003).
   PubMedGoogle Scholar
• Packard BZ, Komoriya A. Intracellular protease activation in apoptosis and cell-mediated cytotoxicity characterized by cell-permeable fluorogenic protease substrates. Cell. Res.18, 238–247 (2008).
   PubMedGoogle Scholar
• Packard BZ, Telford WG, Komoriya A, Henkart PA. Granzyme B activity in target cells detects attack by cytotoxic lymphocytes. J. Immunol.179, 3812–3820 (2007).
   PubMedGoogle Scholar
• Goldberg JE, Sherwood SW, Clayberger C. A novel method for measuring CTL and NK cell-mediated cytotoxicity using annexin V and two-color flow cytometry. J. Immunol. Methods224, 1–9 (1999).
   PubMed Web of Science ®Google Scholar
• Ozdemir O. Flow cytometric cell-mediated cytotoxicity assay. J. Immunol. Methods318, 158–159; author reply 160–151 (2007).
   PubMedGoogle Scholar
• Karawajew L, Jung G, Wolf H, Micheel B, Ganzel K. A flow cytometric long-term cytotoxicity assay. J. Immunol. Methods177, 119–130 (1994).
   PubMedGoogle Scholar
• Mattis AE, Bernhardt G, Lipp M, Forster R. Analyzing cytotoxic T lymphocyte activity: a simple and reliable flow cytometry-based assay. J. Immunol. Methods204, 135–142 (1997).
   PubMed Web of Science ®Google Scholar
• Piriou L, Chilmonczyk S, Genetet N, Albina E. Design of a flow cytometric assay for the determination of natural killer and cytotoxic T-lymphocyte activity in human and in different animal species. Cytometry41, 289–297 (2000).
   PubMedGoogle Scholar
• Flieger D, Gruber R, Schlimok G et al. A novel non-radioactive cellular cytotoxicity test based on the differential assessment of living and killed target and effector cells. J. Immunol. Methods180, 1–13 (1995).
   PubMedGoogle Scholar
• Hatam L, Schuval S, Bonagura VR. Flow cytometric analysis of natural killer cell function as a clinical assay. Cytometry16, 59–68 (1994).
   PubMedGoogle Scholar
• Motzer SA, Tsuji J, Hertig V, Johnston SK, Scanlan J. Natural killer cell cytotoxicity: a methods analysis of 51chromium release versus flow cytometry. Biol. Res. Nurs.5, 142–152 (2003).
   PubMedGoogle Scholar
• Hermans IF, Silk JD, Yang J et al. The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo.J. Immunol. Methods285, 25–40 (2004).
   PubMedGoogle Scholar
• Lee-MacAry AE, Ross EL, Davies D et al. Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide. J. Immunol. Methods252, 83–92 (2001).
   PubMedGoogle Scholar
• Wilkinson RW, Lee-MacAry AE, Davies D, Snary D, Ross EL. Antibody-dependent cell-mediated cytotoxicity: a flow cytometry-based assay using fluorophores. J. Immunol. Methods258, 183–191 (2001).
   PubMedGoogle Scholar
• Ozdemir O, Ravindranath Y, Savasan S. Cell-mediated cytotoxicity evaluation using monoclonal antibody staining for target or effector cells with annexin V/propidium iodide colabeling by fluorosphere-adjusted counts on three-color flow cytometry. Cytometry A56, 53–60 (2003).
   PubMed Web of Science ®Google Scholar
• Zimmermann SY, Esser R, Rohrbach E, Klingebiel T, Koehl U. A novel four-colour flow cytometric assay to determine natural killer cell or T-cell-mediated cellular cytotoxicity against leukaemic cells in peripheral or bone marrow specimens containing greater than 20% of normal cells. J. Immunol. Methods296, 63–76 (2005).
   PubMedGoogle Scholar
• Kloss S, Bochennek K, Huenecke S et al. A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells. J. Immunol. Methods325, 140–147 (2007).
   PubMed Web of Science ®Google Scholar
• Aubry JP, Blaecke A, Lecoanet-Henchoz S et al. Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity. Cytometry37, 197–204 (1999).
   PubMedGoogle Scholar
• Lecoeur H, Fevrier M, Garcia S, Riviere Y, Gougeon ML. A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J. Immunol. Methods253, 177–187 (2001).
   PubMed Web of Science ®Google Scholar
• Derby E, Reddy V, Kopp W et al. Three-color flow cytometric assay for the study of the mechanisms of cell-mediated cytotoxicity. Immunol. Lett.78, 35–39 (2001).
   PubMedGoogle Scholar
• Malyguine A, Derby E, Brooks A et al. Study of diverse mechanisms of cell-mediated cytotoxicity in gene-targeted mice using flow cytometric cytotoxicity assay. Immunol. Lett.83, 55–59 (2002).
   PubMedGoogle Scholar
• Altman JD, Moss PA, Goulder PJ et al. Phenotypic analysis of antigen-specific T lymphocytes. Science274, 94–96 (1996).
   PubMed Web of Science ®Google Scholar
• Tesfa L, Volk HD, Kern F. A protocol for combining proliferation, tetramer staining and intracellular cytokine detection for the flow-cytometric analysis of antigen specific T-cells. J. Biol. Regul. Homeost. Agents17, 366–370 (2003).
   PubMedGoogle Scholar
• Guillaume P, Dojcinovic D, Luescher IF. Soluble MHC-peptide complexes: tools for the monitoring of T cell responses in clinical trials and basic research. Cancer Immun.9, 7 (2009).
   PubMedGoogle Scholar
• Jung T, Schauer U, Heusser C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods159, 197–207 (1993).
   PubMed Web of Science ®Google Scholar
• Kern F, Surel IP, Brock C et al. T-cell epitope mapping by flow cytometry. Nat. Med.4, 975–978 (1998).
   PubMed Web of Science ®Google Scholar
• Maino VC, Maecker HT. Cytokine flow cytometry: a multiparametric approach for assessing cellular immune responses to viral antigens. Clin. Immunol.110, 222–231 (2004).
   PubMedGoogle Scholar
• Maecker HT, Maino VC. Analyzing T-cell responses to cytomegalovirus by cytokine flow cytometry. Hum. Immunol.65, 493–499 (2004).
   PubMed Web of Science ®Google Scholar
• Badovinac VP, Harty JT. Detection and analysis of antigen-specific CD8+ T cells. Immunol. Res.24, 325–332 (2001).
   PubMedGoogle Scholar
• Appay V, Rowland-Jones SL. The assessment of antigen-specific CD8+ T cells through the combination of MHC class I tetramer and intracellular staining. J. Immunol. Methods268, 9–19 (2002).
   PubMed Web of Science ®Google Scholar
• Mackensen A, Veelken H, Lahn M et al. Induction of tumor-specific cytotoxic T lymphocytes by immunization with autologous tumor cells and interleukin-2 gene transfected fibroblasts. J. Mol. Med.75, 290–296 (1997).
   PubMedGoogle Scholar
• Eskelinen EL. Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol. Aspects Med.27, 495–502 (2006).
   PubMedGoogle Scholar
• Betts MR, Brenchley JM, Price DA et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods281, 65–78 (2003).
   PubMed Web of Science ®Google Scholar
• Betts MR, Koup RA. Detection of T-cell degranulation: CD107a and b. Methods Cell. Biol.75, 497–512 (2004).
   PubMed Web of Science ®Google Scholar
• Casazza JP, Betts MR, Price DA et al. Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J. Exp. Med.203, 2865–2877 (2006).
   PubMed Web of Science ®Google Scholar
• Rubio V, Stuge TB, Singh N et al.Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat. Med.9, 1377–1382 (2003).
   PubMed Web of Science ®Google Scholar
• Kaufman HL, Taback B, Sherman W et al. Phase II trial of modified vaccinia Ankara (MVA) virus expressing 5T4 and high dose interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma. J. Transl. Med.7, 2 (2009).
   PubMed Web of Science ®Google Scholar
• Walker EB, Haley D, Petrausch U et al. Phenotype and functional characterization of long-term gp100-specific memory CD8+ T cells in disease-free melanoma patients before and after boosting immunization. Clin. Cancer Res.14, 5270–5283 (2008).
   PubMed Web of Science ®Google Scholar
• Alter G, Malenfant JM, Delabre RM et al. Increased natural killer cell activity in viremic HIV-1 infection. J. Immunol.173(8), 5305–5311 (2004).
   PubMedGoogle Scholar
• Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods294, 15–22 (2004).
   PubMed Web of Science ®Google Scholar
• Tomescu C, Chehimi J, Maino VC, Montaner LJ. Retention of viability, cytotoxicity, and response to IL-2, IL-15, or IFN-α by human NK cells after CD107a degranulation. J. Leukoc. Biol.85, 871–876 (2009).
   PubMedGoogle Scholar
• Kim GG, Donnenberg VS, Donnenberg AD, Gooding W, Whiteside TL. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay. J. Immunol. Methods325, 51–66 (2007).
   PubMed Web of Science ®Google Scholar
• Devevre E, Romero P, Mahnke YD. LiveCount Assay: concomitant measurement of cytolytic activity and phenotypic characterisation of CD8+ T-cells by flow cytometry. J. Immunol. Methods311, 31–46 (2006).
   PubMedGoogle Scholar
• Burkett MW, Shafer-Weaver KA, Strobl S, Baseler M, Malyguine A. A novel flow cytometric assay for evaluating cell-mediated cytotoxicity. J. Immunother.28, 396–402 (2005).
   PubMed Web of Science ®Google Scholar
• Zaritskaya L, Shafer-Weaver KA, Gregory MK et al. Application of a flow cytometric cytotoxicity assay for monitoring cancer vaccine trials. J. Immunother.32, 186–194 (2009).
   PubMedGoogle Scholar
• Cohen AM, Burdick JF, Ketcham AS. Cell-mediated cytotoxicity: an assay using 125I-iododeoxyuridine-labeled target cells. J. Immunol.107, 895–898 (1971).
   PubMedGoogle Scholar
• Le Mevel BP, Oldham RK, Wells SA, Herberman RB. An evaluation of 125I-iododeoxyuridine as a cellular label for in vitro assays: kinetics of incorporation and toxicity. J. Natl Cancer Inst.51, 1551–1558 (1973).
   PubMedGoogle Scholar
• Jagarlamoody SM, Aust JC, Tew RH, McKhann CF. In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique. Proc. Natl Acad. Sci. USA68, 1346–1350 (1971).
   PubMedGoogle Scholar
• Matzinger P. The JAM test. A simple assay for DNA fragmentation and cell death. J. Immunol. Methods145, 185–192 (1991).
   PubMed Web of Science ®Google Scholar
• Blomberg K, Granberg C, Hemmila I, Lovgren T. Europium-labelled target cells in an assay of natural killer cell activity. I. A novel non-radioactive method based on time-resolved fluorescence. J. Immunol. Methods86, 225–229 (1986).
   PubMed Web of Science ®Google Scholar
• Cui J, Bystryn JC. An improved europium release assay for complement-mediated cytolysis. J. Immunol. Methods147, 13–19 (1992).
   PubMed Web of Science ®Google Scholar
• von Zons P, Crowley-Nowick P, Friberg D et al. Comparison of europium and chromium release assays: cytotoxicity in healthy individuals and patients with cervical carcinoma. Clin. Diagn. Lab. Immunol.4, 202–207 (1997).
   PubMedGoogle Scholar
• Bruning JW, Kardol MJ, Arentzen R. Carboxyfluorescein fluorochromasia assays. I. Non-radioactively labeled cell mediated lympholysis. J. Immunol. Methods33, 33–44 (1980).
   PubMed Web of Science ®Google Scholar
• Wierda WG, Mehr DS, Kim YB. Comparison of fluorochrome-labeled and 51Cr-labeled targets for natural killer cytotoxicity assay. J. Immunol. Methods122, 15–24 (1989).
   PubMedGoogle Scholar
• Kolber MA, Quinones RR, Gress RE, Henkart PA. Measurement of cytotoxicity by target cell release and retention of the fluorescent dye bis-carboxyethyl-carboxyfluorescein (BCECF). J. Immunol. Methods108, 255–264 (1988).
   PubMed Web of Science ®Google Scholar
• Szekeres J, Pacsa AS, Pejtsik B. Measurement of lymphocyte cytotoxicity by assessing endogenous alkaline phosphatase activity of the target cells. J. Immunol. Methods40, 151–154 (1981).
   PubMed Web of Science ®Google Scholar
• Sepp A, Binns RM, Lechler RI. Improved protocol for colorimetric detection of complement-mediated cytotoxicity based on the measurement of cytoplasmic lactate dehydrogenase activity. J. Immunol. Methods196, 175–180 (1996).
   PubMedGoogle Scholar
• Korzeniewski C, Callewaert DM. An enzyme-release assay for natural cytotoxicity. J. Immunol. Methods64, 313–320 (1983).
   PubMed Web of Science ®Google Scholar
• Kruger-Krasagakes S, Garbe C, Kossman P, Orfanos CE. A rapid and sensitive fluorometric microassay for determining cell mediated cytotoxicity to adherent growing cell lines. J. Immunol. Methods156, 1–8 (1992).
   PubMedGoogle Scholar
• Virag L, Kerekgyarto C, Fachet J. A simple, rapid and sensitive fluorimetric assay for the measurement of cell-mediated cytotoxicity. J. Immunol. Methods185, 199–208 (1995).
   PubMedGoogle Scholar
• Lichtenfels R, Biddison WE, Schulz H, Vogt AB, Martin R. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J. Immunol. Methods172, 227–239 (1994).
   PubMed Web of Science ®Google Scholar
• Roden MM, Lee KH, Panelli MC, Marincola FM. A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology. J. Immunol. Methods226, 29–41 (1999).
   PubMedGoogle Scholar
• Page M, Bejaoui N, Cinq-Mars B, Lemieux P. Optimization of the tetrazolium-based colorimetric assay for the measurement of cell number and cytotoxicity. Int. J. Immunopharmacol.10, 785–793 (1988).
   PubMed Web of Science ®Google Scholar
• Memon SA, Petrak D, Moreno MB, Zacharchuk CM. A simple assay for examining the effect of transiently expressed genes on programmed cell death. J. Immunol. Methods180, 15–24 (1995).
   PubMedGoogle Scholar
• Schafer H, Schafer A, Kiderlen AF, Masihi KN, Burger R. A highly sensitive cytotoxicity assay based on the release of reporter enzymes, from stably transfected cell lines. J. Immunol. Methods204, 89–98 (1997).
   PubMed Web of Science ®Google Scholar
• Bachy M, Bonnin-Rivalland A, Tilliet V, Trannoy E. b galactosidase release as an alternative to chromium release in cytotoxic T-cell assays. J. Immunol. Methods230, 37–46 (1999).
   PubMedGoogle Scholar
• Snyder JE, Bowers WJ, Livingstone AM et al. Measuring the frequency of mouse and human cytotoxic T cells by the Lysispot assay: independent regulation of cytokine secretion and short-term killing. Nat. Med.9, 231–235 (2003).
   PubMed Web of Science ®Google Scholar
• Gupta P, Tayal R, Durgapal H et al. Development of highly sensitive Bicistronic vector based non-radioactive antigen-specific cytotoxicity assay. J. Immunol. Methods349, 28–37 (2009).
   PubMedGoogle Scholar
• Takayama H, Trenn G, Sitkovsky MV. A novel cytotoxic T lymphocyte activation assay. Optimized conditions for antigen receptor triggered granule enzyme secretion. J. Immunol. Methods104, 183–190 (1987).
   PubMedGoogle Scholar
• Suhrbier A, Fernan A, Burrows SR, Saul A, Moss DJ. BLT esterase activity as an alternative to chromium release in cytotoxic T cell assays. J. Immunol. Methods145, 43–53 (1991).
   PubMedGoogle Scholar
• Weren A, Bonnekoh B, Schraven B, Gollnick H, Ambach A. A novel flow cytometric assay focusing on perforin release mechanisms of cytotoxic T lymphocytes. J. Immunol. Methods289, 17–26 (2004).
   PubMedGoogle Scholar
• Clay TM, Hobeika AC, Mosca PJ, Lyerly HK, Morse MA. Assays for monitoring cellular immune responses to active immunotherapy of cancer. Clin. Cancer Res.7, 1127–1135 (2001).
   PubMed Web of Science ®Google Scholar
• Suni MA, Maino VC, Maecker HT. Ex vivo analysis of T-cell function. Curr. Opin. Immunol.17, 434–440 (2005).
   PubMedGoogle Scholar
• Vuillier F, Scott-Algara D, Cayota A et al. Flow cytometric analysis of protein-tyrosine phosphorylation in peripheral T cell subsets. Application to healthy and HIV-seropositive subjects. J. Immunol. Methods185, 43–56 (1995).
   PubMed Web of Science ®Google Scholar
• Krutzik PO, Irish JM, Nolan GP, Perez OD. Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications. Clin. Immunol.110, 206–221 (2004).
   PubMed Web of Science ®Google Scholar
• D’Souza S, Rimoldi D, Lienard D et al. Circulating Melan-A/Mart-1 specific cytolytic T lymphocyte precursors in HLA-A2+ melanoma patients have a memory phenotype. Int. J. Cancer78, 699–706 (1998).
   PubMed Web of Science ®Google Scholar
• Sun Y, Jurgovsky K, Moller P et al. Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical Phase I study. Gene Ther.5, 481–490 (1998).
   PubMed Web of Science ®Google Scholar
• Hoppner M, Luhm J, Schlenke P, Koritke P, Frohn C. A flow-cytometry based cytotoxicity assay using stained effector cells in combination with native target cells. J. Immunol. Methods267, 157–163 (2002).
   PubMed Web of Science ®Google Scholar
• Papadopoulos NG, Dedoussis GV, Spanakos G et al. An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry. J. Immunol. Methods177, 101–111 (1994).
   PubMed Web of Science ®Google Scholar
• Kasatori N, Ishikawa F, Ueyama M, Urayama T. A differential assay of NK-cell-mediated cytotoxicity in K562 cells revealing three sequential membrane impairment steps using three-color flow-cytometry. J. Immunol. Methods307, 41–53 (2005).
   PubMedGoogle Scholar
• Sheehy ME, McDermott AB, Furlan SN, Klenerman P, Nixon DF. A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis. J. Immunol. Methods249, 99–110 (2001).
   PubMed Web of Science ®Google Scholar
• Fischer K, Andreesen R, Mackensen A. An improved flow cytometric assay for the determination of cytotoxic T lymphocyte activity. J. Immunol. Methods259, 159–169 (2002).
   PubMedGoogle Scholar
• Kienzle N, Olver S, Buttigieg K, Kelso A. The fluorolysis assay, a highly sensitive method for measuring the cytolytic activity of T cells at very low numbers. J. Immunol. Methods267, 99–108 (2002).
   PubMedGoogle Scholar
• Chen K, Chen L, Zhao P et al. FL-CTL assay: fluorolysometric determination of cell-mediated cytotoxicity using green fluorescent protein and red fluorescent protein expressing target cells. J. Immunol. Methods300, 100–114 (2005).
   PubMedGoogle Scholar
• van Baalen CA, Gruters RA, Berkhoff EG, Osterhaus AD, Rimmelzwaan GF. FATT-CTL assay for detection of antigen-specific cell-mediated cytotoxicity. Cytometry A73, 1058–1065 (2008).
   PubMed Web of Science ®Google Scholar
• Bonci F, Zabogli E, Freer G et al. A new fluorimetric assay to measure cytotoxic T-lymphocyte activity against feline immunodeficiency virus envelope glycoprotein. Vet. Immunol. Immunopathol.123, 150–153 (2008).
   PubMedGoogle Scholar
• Bonci F, Zabogli E, Conti F et al. A novel method for producing target cells and assessing cytotoxic T lymphocyte activity in outbred hosts. BMC Biotechnol.9, 18 (2009).
   PubMedGoogle Scholar
• Jerome KR, Sloan DD, Aubert M. Measuring T-cell-mediated cytotoxicity using antibody to activated caspase 3. Nat. Med.9, 4–5 (2003).
   PubMedGoogle Scholar
• Brown CE, Wright CL, Naranjo A et al. Biophotonic cytotoxicity assay for high-throughput screening of cytolytic killing. J. Immunol. Methods297, 39–52 (2005).
   PubMed Web of Science ®Google Scholar
• Derby E, Reddy V, Baseler M, Malyguine A. Flow cytometric assay for the simultaneous analysis of cell-mediated cytotoxicity and effector cell phenotype. Biotechniques31, 660, 664–665 (2001).
   PubMed Web of Science ®Google Scholar
• Ozdemir O, Ravindranath Y, Savasan S. Mechanisms of superior anti-tumor cytotoxic response of interleukin 15-induced lymphokine-activated killer cells. J. Immunother.28, 44–52 (2005).
   PubMedGoogle Scholar
• Ozdemir O, Savasan S. Combinational IL-2/IL-15 induction does not further enhance IL-15-induced lymphokine-activated killer cell cytotoxicity against human leukemia/lymphoma cells. Clin. Immunol.115, 240–249 (2005).
   PubMedGoogle Scholar
• Langhans B, Ahrendt M, Nattermann J, Sauerbruch T, Spengler U. Comparative study of NK cell-mediated cytotoxicity using radioactive and flow cytometric cytotoxicity assays. J. Immunol. Methods306, 161–168 (2005).
   PubMedGoogle Scholar
• Wolint P, Betts MR, Koup RA, Oxenius A. Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells. J. Exp. Med.199, 925–936 (2004).
   PubMedGoogle Scholar
• Kohrt HE, Shu CT, Stuge TB et al. Rapid assessment of recognition efficiency and functional capacity of antigen-specific T-cell responses. J. Immunother.28, 297–305 (2005).
   PubMedGoogle Scholar
• McElroy DS, Badstibner AM, D’Orazio SE. Use of the CD107 mobilization assay reveals that cytotoxic T lymphocytes with novel MHC-Ib restriction are activated during Listeria monocytogenes infection. J. Immunol. Methods328, 45–52 (2007).
   PubMedGoogle Scholar
• Prussin C, Metcalfe DD. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J. Immunol. Methods188, 117–128 (1995).
   PubMedGoogle Scholar
• Prussin C. Cytokine flow cytometry: understanding cytokine biology at the single-cell level. J. Clin. Immunol.17, 195–204 (1997).
   PubMed Web of Science ®Google Scholar
• Slifka MK, Whitton JL. Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers. J. Immunol.164, 208–216 (2000).
   PubMedGoogle Scholar
• Kowalczyk DW, Wlazlo AP, Giles-Davis W, Ertl HC. Staining of antigen activated lymphocytes (SAAL): a highly specific method for flow cytometric quantitation of tumor-specific CD8+ T cells. J. Immunol. Methods241, 131–139 (2000).
   PubMedGoogle Scholar
• Altman JD, Davis MM. MHC-peptide tetramers to visualize antigen-specific T cells. Curr. Protoc. Immunol.17(17), 13 (2003).
   Google Scholar
• Chattopadhyay PK, Melenhorst JJ, Ladell K et al. Techniques to improve the direct ex vivo detection of low frequency antigen-specific CD8+ T cells with peptide-major histocompatibility complex class I tetramers. Cytometry A73, 1001–1009 (2008).
   PubMedGoogle Scholar
• Melenhorst JJ, Scheinberg P, Chattopadhyay PK et al. Detection of low avidity CD8+ T cell populations with coreceptor-enhanced peptide-major histocompatibility complex class I tetramers. J. Immunol. Methods338, 31–39 (2008).
   PubMed Web of Science ®Google Scholar
• Peters PJ, Borst J, Oorschot V et al. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J. Exp. Med.173, 1099–1109 (1991).
   PubMed Web of Science ®Google Scholar
• Huang JF, Yang Y, Sepulveda H et al. TCR-mediated internalization of peptide–MHC complexes acquired by T cells. Science286, 952–954 (1999).
   PubMedGoogle Scholar
• Hudrisier D, Riond J, Mazarguil H, Gairin JE, Joly E. Cutting edge: CTLs rapidly capture membrane fragments from target cells in a TCR signaling-dependent manner. J. Immunol.166, 3645–3649 (2001).
   PubMed Web of Science ®Google Scholar
• Poupot M, Fournie JJ. Spontaneous membrane transfer through homotypic synapses between lymphoma cells. J. Immunol.171, 2517–2523 (2003).
   PubMedGoogle Scholar
• Puaux AL, Campanaud J, Salles A et al. A very rapid and simple assay based on trogocytosis to detect and measure specific T and B cell reactivity by flow cytometry. Eur J. Immunol.36, 779–788 (2006).
   PubMedGoogle Scholar
• Godoy-Ramirez K, Franck K, Gaines H. A novel method for the simultaneous assessment of natural killer cell conjugate formation and cytotoxicity at the single-cell level by multi-parameter flow cytometry. J. Immunol. Methods239, 35–44 (2000).
   PubMedGoogle Scholar
• Lin SJ, Cheng PJ, Huang YJ, Kuo ML. Evaluation of cytotoxic function and apoptosis in interleukin (IL)-12/IL-15-treated umbilical cord or adult peripheral blood natural killer cells by a propidium-iodide based flow cytometry. Pediatr. Allergy Immunol.15, 79–85 (2004).
   PubMedGoogle Scholar